Economic and Utilization Outcomes Associated with Choice of Treatment for Venous Thromboembolism in Hospitalized Patients
- 1 May 2005
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 8 (3), 191-200
- https://doi.org/10.1111/j.1524-4733.2005.04026.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tracking the Uptake of EvidenceArchives of Internal Medicine, 2003
- American Heart Association/American College of Cardiology Foundation Guide to Warfarin TherapyCirculation, 2003
- Direct medical cost of managing deep vein thrombosis according to the occurrence of complications.PharmacoEconomics, 2002
- Proficient and Cost-Effective Approaches for the Prevention and Treatment of Venous Thrombosis and ThromboembolismDrugs, 2000
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1999
- Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective ApproachClinical and Applied Thrombosis/hemostasis, 1999
- Use of Low-Molecular-Weight Heparin in the Treatment of Venous Thromboembolic Disease: Answers to Frequently Asked QuestionsMayo Clinic Proceedings, 1998
- Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic EvaluationThrombosis and Haemostasis, 1998
- Current Concepts in Anticoagulant TherapyMayo Clinic Proceedings, 1995
- A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary EmbolismArchives of Internal Medicine, 1991